Cargando…

Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review

BACKGROUND: The underreporting of adverse drug reactions (ADRs) through traditional reporting channels is a limitation in the efficiency of the current pharmacovigilance system. Patients’ experiences with drugs that they report on social media represent a new source of data that may have some value...

Descripción completa

Detalles Bibliográficos
Autores principales: Lardon, Jérémy, Abdellaoui, Redhouane, Bellet, Florelle, Asfari, Hadyl, Souvignet, Julien, Texier, Nathalie, Jaulent, Marie-Christine, Beyens, Marie-Noëlle, Burgun, Anita, Bousquet, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526988/
https://www.ncbi.nlm.nih.gov/pubmed/26163365
http://dx.doi.org/10.2196/jmir.4304
_version_ 1782384509396713472
author Lardon, Jérémy
Abdellaoui, Redhouane
Bellet, Florelle
Asfari, Hadyl
Souvignet, Julien
Texier, Nathalie
Jaulent, Marie-Christine
Beyens, Marie-Noëlle
Burgun, Anita
Bousquet, Cédric
author_facet Lardon, Jérémy
Abdellaoui, Redhouane
Bellet, Florelle
Asfari, Hadyl
Souvignet, Julien
Texier, Nathalie
Jaulent, Marie-Christine
Beyens, Marie-Noëlle
Burgun, Anita
Bousquet, Cédric
author_sort Lardon, Jérémy
collection PubMed
description BACKGROUND: The underreporting of adverse drug reactions (ADRs) through traditional reporting channels is a limitation in the efficiency of the current pharmacovigilance system. Patients’ experiences with drugs that they report on social media represent a new source of data that may have some value in postmarketing safety surveillance. OBJECTIVE: A scoping review was undertaken to explore the breadth of evidence about the use of social media as a new source of knowledge for pharmacovigilance. METHODS: Daubt et al’s recommendations for scoping reviews were followed. The research questions were as follows: How can social media be used as a data source for postmarketing drug surveillance? What are the available methods for extracting data? What are the different ways to use these data? We queried PubMed, Embase, and Google Scholar to extract relevant articles that were published before June 2014 and with no lower date limit. Two pairs of reviewers independently screened the selected studies and proposed two themes of review: manual ADR identification (theme 1) and automated ADR extraction from social media (theme 2). Descriptive characteristics were collected from the publications to create a database for themes 1 and 2. RESULTS: Of the 1032 citations from PubMed and Embase, 11 were relevant to the research question. An additional 13 citations were added after further research on the Internet and in reference lists. Themes 1 and 2 explored 11 and 13 articles, respectively. Ways of approaching the use of social media as a pharmacovigilance data source were identified. CONCLUSIONS: This scoping review noted multiple methods for identifying target data, extracting them, and evaluating the quality of medical information from social media. It also showed some remaining gaps in the field. Studies related to the identification theme usually failed to accurately assess the completeness, quality, and reliability of the data that were analyzed from social media. Regarding extraction, no study proposed a generic approach to easily adding a new site or data source. Additional studies are required to precisely determine the role of social media in the pharmacovigilance system.
format Online
Article
Text
id pubmed-4526988
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher JMIR Publications Inc.
record_format MEDLINE/PubMed
spelling pubmed-45269882015-08-11 Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review Lardon, Jérémy Abdellaoui, Redhouane Bellet, Florelle Asfari, Hadyl Souvignet, Julien Texier, Nathalie Jaulent, Marie-Christine Beyens, Marie-Noëlle Burgun, Anita Bousquet, Cédric J Med Internet Res Review BACKGROUND: The underreporting of adverse drug reactions (ADRs) through traditional reporting channels is a limitation in the efficiency of the current pharmacovigilance system. Patients’ experiences with drugs that they report on social media represent a new source of data that may have some value in postmarketing safety surveillance. OBJECTIVE: A scoping review was undertaken to explore the breadth of evidence about the use of social media as a new source of knowledge for pharmacovigilance. METHODS: Daubt et al’s recommendations for scoping reviews were followed. The research questions were as follows: How can social media be used as a data source for postmarketing drug surveillance? What are the available methods for extracting data? What are the different ways to use these data? We queried PubMed, Embase, and Google Scholar to extract relevant articles that were published before June 2014 and with no lower date limit. Two pairs of reviewers independently screened the selected studies and proposed two themes of review: manual ADR identification (theme 1) and automated ADR extraction from social media (theme 2). Descriptive characteristics were collected from the publications to create a database for themes 1 and 2. RESULTS: Of the 1032 citations from PubMed and Embase, 11 were relevant to the research question. An additional 13 citations were added after further research on the Internet and in reference lists. Themes 1 and 2 explored 11 and 13 articles, respectively. Ways of approaching the use of social media as a pharmacovigilance data source were identified. CONCLUSIONS: This scoping review noted multiple methods for identifying target data, extracting them, and evaluating the quality of medical information from social media. It also showed some remaining gaps in the field. Studies related to the identification theme usually failed to accurately assess the completeness, quality, and reliability of the data that were analyzed from social media. Regarding extraction, no study proposed a generic approach to easily adding a new site or data source. Additional studies are required to precisely determine the role of social media in the pharmacovigilance system. JMIR Publications Inc. 2015-07-10 /pmc/articles/PMC4526988/ /pubmed/26163365 http://dx.doi.org/10.2196/jmir.4304 Text en ©Jérémy Lardon, Redhouane Abdellaoui, Florelle Bellet, Hadyl Asfari, Julien Souvignet, Nathalie Texier, Marie-Christine Jaulent, Marie-Noëlle Beyens, Anita Burgun, Cédric Bousquet. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 10.07.2015. https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/ (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Review
Lardon, Jérémy
Abdellaoui, Redhouane
Bellet, Florelle
Asfari, Hadyl
Souvignet, Julien
Texier, Nathalie
Jaulent, Marie-Christine
Beyens, Marie-Noëlle
Burgun, Anita
Bousquet, Cédric
Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title_full Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title_fullStr Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title_full_unstemmed Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title_short Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
title_sort adverse drug reaction identification and extraction in social media: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526988/
https://www.ncbi.nlm.nih.gov/pubmed/26163365
http://dx.doi.org/10.2196/jmir.4304
work_keys_str_mv AT lardonjeremy adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT abdellaouiredhouane adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT belletflorelle adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT asfarihadyl adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT souvignetjulien adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT texiernathalie adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT jaulentmariechristine adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT beyensmarienoelle adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT burgunanita adversedrugreactionidentificationandextractioninsocialmediaascopingreview
AT bousquetcedric adversedrugreactionidentificationandextractioninsocialmediaascopingreview